Episode 538 - Uromigos Live 2026 – Triplet Therapy in mRCC: What Went Wrong?
From The Uromigos · · 45 min
This plays from the publisher's own server. We do not host a copy.
Not rated yet
Description
Recent attempts to build on the IO-doublet backbone in front-line clear cell RCC therapy have failed including LITESPARK-012. The panel discusses issues that have impacted these trials and where we go from here.